Convertibles Calendar: Mirum Pharmaceuticals on tap

April 12

MIRUM PHARMACEUTICALS INC.

• $200 million six-year convertible notes

• $30 million greenshoe

• Fixed coupon of 4% and fixed initial conversion premium of 32.5%

• Non-callable until May 5, 2026 and then are redeemable for cash subject to a 130% hurdle

• Rule 144A

• J.P. Morgan Securities LLC (lead left) and Evercore ISI

• Proceeds to repurchase the revenue interests under the Revenue Interest Purchase Agreement with an affiliate of Oberland Capital Management LLC

• Foster City, Calif.-based biopharmaceutical company

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.